Clinical Trials Browser

Unknown × Ovarian Neoplasms × Docetaxel × Clear all

NCT05158062 2022-04-26

Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer

Phase 2 Unknown

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00075543 2008-07-24

Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Phase 1/2 Unknown

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms